Home Healthcare Market Size, Share & Analysis Report, 2025-2034
The home healthcare market size was exhibited at USD 421.34 billion in 2024 and is projected to hit around USD 907.12 billion by 2034, growing at a CAGR of 7.97% during the forecast period 2025 to 2034.
The U.S. home healthcare market size is evaluated at USD 135.9 billion in 2024 and is projected to be worth around USD 292.5 billion by 2034, growing at a CAGR of 7.21% from 2025 to 2034.
North America accounted for the largest market share of 43.0% in 2024. The large geriatric population in this region, coupled with sophisticated healthcare infrastructure and relatively high disposable incomes, are some key drivers of this market. Moreover, an increasing number of government initiatives that aim to curb healthcare expenditure levels, by promoting home healthcare is expected to serve as a vital impact-rendering driver.
In addition, by 2030, one in five Americans will be above 65 years of age. Around 90% of the population aged above 65 in the U.S. is expected to have one or more chronic diseases requiring long-term care. Home healthcare services are very useful for the geriatric population, as they enable elderly people to manage chronic conditions at home, thereby reducing hospital visits and the cost of treatment.
Asia Pacific has been estimated to be the fastest-growing segment. Factors such as underdeveloped healthcare infrastructure, expensive in-hospital healthcare facilities, and chronic diseases that require long-term care are resulting in an increase in home healthcare products and services. Thailand, Australia, India, South Korea, and New Zealand are some of the emerging countries in the region. Technological advancements in patient monitoring devices and an increasing geriatric population coupled with the growing prevalence of lifestyle diseases, such as obesity & diabetes, are anticipated to drive the growth of the market.
India home healthcare market
The market is expected to witness significant growth over the forecast period owing to the need for better primary and postoperative care and demand for cost-effective alternative for hospital services.
UAE home healthcare market
The market held significant market share in MEA region owing to growing number of facilities offering home healthcare services. Some of key players operating in UAE include Al Tawam Hospital, Sheikh Khalifa Medical City in Abu Dhabi city, and others.
Saudi Arabia home healthcare market
Home care services in Saudi Arabia are growing at a significant pace owing to growing patient volumes in hospitals, changing healthcare reforms such as shift towards value-based care services.
| Report Coverage | Details |
| Market Size in 2025 | USD 454.92 Billion |
| Market Size by 2034 | USD 907.12 Billion |
| Growth Rate From 2025 to 2034 | CAGR of 7.97% |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Segments Covered | Component, Indication, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Key Companies Profiled | B. Braun Melsungen AG; Abbott; Sunrise Medical; 3M Healthcare; Baxter International Inc.; Medtronic PLC; Cardinal Health Inc; F. Hoffmann-La Roche AG; Air Liquide; Amedisys, Inc; NxStage Medical, Inc. (Fresenius Medical Care); Arkray, Inc.; Becton, Dickinson and Company; Omron Healthcare, Inc; Drive DeVilbiss Healthcare; GE Healthcare; Medline Industries, Inc; Koninklijke Philips N.V; Johnson & Johnson Services, Inc.; Linde Healthcare; Acelity (3M); Vygon; Teleflex, Inc; Moog Inc.; Intersurgical Ltd.; Fresenius Kabi AG; GF Health Products, Inc. |
The services segment dominated the market and held the largest revenue share of 85.0% in 2024. The market by services is segmented into skilled home healthcare and unskilled home healthcare. Skilled services are provided by healthcare professionals. Unskilled services includes non-medical home care services provided for daily living aid to home-bound patients and are categorized as basic assistance care/personal care service. Rising medical expenditure associated with hospital stays is expected to boost the demand for skilled care.
Under skilled nursing services, medical professionals such as physicians, registered nurses, physiotherapists, and specialty care providers aid patients at home or home care centers. The aging population suffering from diseases, such as diabetes and cardiac disorders, require medical assistance services such as medication management and continuous monitoring. With advancements in medical technology, many procedures can be performed at home in a more comfortable and convenient environment, which can be attributed to the growth of skilled home care services in the market for home healthcare.
Equipment is segmented as therapeutic, diagnostic, and mobility assistance. Diagnostics accounted for largest share in 2024 and is expected to gain a lucrative share over the forecast period. Technologically advanced products that enable accurate and timely diagnosis, such as remote heart rate monitor, iPhone heart-rate monitor, and TQR heart rate watches are likely to propel the diagnostic equipment segment growth. Further, increasing patient awareness and health consciousness is also likely to boost segment growth.
Neurological & mental disorder accounted for the largest revenue share in 2024 owing to increasing disease prevalence. Neurological disorders, including epilepsy, Alzheimer's & other dementias, stroke, migraine & other headaches, multiple sclerosis, and Parkinson's disease, can affect the functioning of the brain, spine, and nerves. Home healthcare services, such as physical therapy, occupational therapy, speech therapy, and mental health services, can help those with such disorders manage symptoms. According to the NCBI, in 2022, an estimated 6.5 million people aged 65 and over in the US were suffering from Alzheimer's disease, which is expected to rise to 13.8 million by 2060. In addition, women are more likely to be diagnosed with Alzheimer’s than men due to their longer life expectancy, and it is becoming the most common cause of death in neurodegenerative diseases, as well as a common cause of physical disability that requires urgent treatment.
Mobility disorders have been estimated to be the fastest growing segment. According to the CDC, 11.1% of U.S. adults have a mobility-related disability with serious difficulty walking or climbing stairs. Mobility disorders are conditions that limit movement due to physical, psychological, or neurological impairment, and treatment may include physical therapy, assistive devices, and medications. Home healthcare services can provide numerous benefits to individuals with mobility disorders, such as assistance with daily tasks & activities to help maintain independence and physiotherapists to help regain mobility, functionality, & strength & reduce pain through exercise, movements, & massage. The increasing prevalence of mobility disorders is expected to drive the growth of this segment over the forecast period.
Diabetes is one of the leading causes of disability & death worldwide, and the number of people living with diabetes is expected to grow in the coming years. This growing prevalence of diabetes is expected to have a significant impact on the growth of the home healthcare services market. For instance, according to the International Diabetes Federation estimates, in 2021, approximately 536 million adults were living with diabetes, and this number is expected to increase to 783 million by 2045. Home healthcare services can enable people with diabetes to manage their conditions in the comfort of their homes, thereby reducing the need for hospital visits and the overall cost of care. Such services can involve care planning, monitoring, and education, as well as providing diabetes-related equipment & supplies.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the home healthcare market
By Component
By Indication
By Regional
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Component
1.2.2. Indication
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources & Third-Party Perspectives
1.5.4. Primary Research
1.5.5. Details of Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.7.1. Commodity Flow Analysis
1.7.1.1. Approach 1: Commodity flow approach
1.7.1.2. Approach 2: Country wise market estimation using bottom up approach
1.8. Data Validation & Publishing
1.9. Global Market: CAGR Calculation
1.10. List of Secondary Sources
1.11. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segmental Snapshot
2.3. Competitive Insights Snapshot
Chapter 3. Market Variables, Trends, and Scope
3.1. Market Lineage
3.1.1. Parent Market Analysis
3.1.2. Ancillary Market Analysis
3.2. Home Healthcare Market - Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Home healthcare as a cost-effective alternative
3.2.1.2. Hospital solution providers penetrating the home healthcare market
3.2.1.3. Geographical expansion of services by providers
3.2.1.4. Advancement in technology
3.2.2. Market Restraint Analysis
3.2.2.1. Lower remunerations
3.2.2.2. Shortage of skilled healthcare staff
3.2.2.3. Complicated reimbursement framework and reimbursement cuts
3.3. Business Environmental Tools Analysis: Home Healthcare Market
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTLE Analysis
Chapter 4. Home Healthcare Market: Component Estimates & Trend Analysis
4.1. Home Healthcare Market, By Component Key Takeaways
4.2. Home Healthcare Market: Component Movement & Market Share Analysis, 2023 & 2030
4.3. Services
4.3.1. Global Home Healthcare Services Market Estimates and Forecasts, 2021 - 2034 (USD Million)
4.3.2. Skilled home healthcare
4.3.2.1. Global skilled home healthcare services market estimates and forecasts, 2021 - 2034 (USD Million)
4.3.2.2. Nursing care
4.3.2.2.1. Global nursing care market estimates and forecasts, 2021 - 2034 (USD Million)
4.3.2.3. Physician primary care
4.3.2.3.1. Global physician primary care market estimates and forecasts, 2021 - 2034 (USD Million)
4.3.2.4. Physical/occupational/speech therapy
4.3.2.4.1. Global physical/occupational/speech therapy market estimates and forecasts, 2021 - 2034 (USD Million)
4.3.2.5. Hospice & palliative
4.3.2.5.1. Global hospice & palliative market estimates and forecasts, 2021 - 2034 (USD Million)
4.3.2.6. Nutritional support & infusion therapy
4.3.2.6.1. Global nutritional support market estimates and forecasts, 2021 - 2034 (USD Million)
4.3.2.7. Other skilled home healthcare
4.3.2.7.1. Global other skilled home healthcare services market estimates and forecasts, 2021 - 2034 (USD Million)
4.3.3. Unskilled Home Healthcare
4.3.3.1. Global unskilled home healthcare services market estimates and forecasts, 2021 - 2034 (USD Million)
4.4. Equipment
4.4.1. Global Home Healthcare Equipment Market Estimates and Forecasts, 2021 - 2034 (USD Million)
4.4.2. Therapeutic
4.4.2.1. Global therapeutic home healthcare equipment market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.2.2. Home respiratory therapy
4.4.2.2.1. Global home respiratory therapy market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.2.3. Home intravenous pumps
4.4.2.3.1. Global home IV pumps market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.2.4. Home dialysis equipment
4.4.2.4.1. Global home dialysis equipment market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.2.5. Insulin delivery
4.4.2.5.1. Global insulin delivery market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.2.6. Other therapeutic equipment
4.4.2.6.1. Global other therapeutic equipment market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.3. Diagnostic
4.4.3.1. Global diagnostic home healthcare equipment market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.3.2. Diabetic care unit
4.4.3.2.1. Global diabetic care unit market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.3.3. Blood pressure monitoring
4.4.3.3.1. Global blood pressure monitoring market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.3.4. Multi parameter diagnostics monitors
4.4.3.4.1. Global multi parameter diagnostics market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.3.5. Apnea and sleep monitors
4.4.3.5.1. Global apnea and sleep monitors market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.3.6. Home pregnancy and fertility kits
4.4.3.6.1. Global home pregnancy and fertility kits market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.3.7. Holter monitors
4.4.3.7.1. Global holter monitors market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.3.8. Heart rate meters
4.4.3.8.1. Global heart rate meter market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.3.9. Other diagnostic equipment
4.4.3.9.1. Global other diagnostic equipment market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.4. Mobility Assist Equipment
4.4.4.1. Global mobility assist equipment market estimates and forecasts, 2021 - 2034 (USD Million
4.4.4.2. Wheelchair
4.4.4.2.1. Global wheelchair market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.4.3. Home medical furniture
4.4.4.3.1. Global home medical furniture market estimates and forecasts, 2021 - 2034 (USD Million)
4.4.4.4. Walking assist devices
4.4.4.4.1. Global walking assist devices market estimates and forecasts, 2021 - 2034 (USD Million)
Chapter 5. Home Healthcare Market: Indication Estimates & Trend Analysis
5.1. Home Healthcare Market, By Indication: Key Takeaways
5.2. Home Healthcare Market: Indication Movement & Market Share Analysis, 2023 & 2030
5.3. Neurological & Mental Disorders
5.3.1. Global Neurological & Mental Disorders Market Estimates and Forecasts, 2021 - 2034 (USD Million)
5.4. Diabetes & Kidney Disorders
5.4.1. Global Diabetes & Kidney Disorders Market Estimates and Forecasts, 2021 - 2034 (USD Million)
5.5. Cancer
5.5.1. Global Cancer Market Estimates and Forecasts, 2021 - 2034 (USD Million)
5.6. Respiratory Disease & COPD
5.6.1. Global Respiratory Disease & COPD Market Estimates and Forecasts, 2021 - 2034 (USD Million)
5.7. Mobility Disorders
5.7.1. Global Mobility Disorders Market Estimates and Forecasts, 2021 - 2034 (USD Million)
5.8. Cardiovascular Disorder & Hypertension
5.8.1. Global Cardiovascular Disorder & Hypertension Market Estimates and Forecasts, 2021 - 2034 (USD Million)
5.9. Wound Care
5.9.1. Global Wound Care Market Estimates and Forecasts, 2021 - 2034 (USD Million)
5.10. Maternal Disorders
5.10.1. Global Maternal Disorders Market Estimates and Forecasts, 2021 - 2034 (USD Million)
5.11. Other Indications
5.11.1. Global Other Indications Market Estimates and Forecasts, 2021 - 2034 (USD Million)
Chapter 6. Home Healthcare Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Home Healthcare Market by Region: Key Marketplace Takeaway
6.3. North America
6.3.1. North America Home Healthcare Market Estimates and Forecasts, 2021 - 2034 (USD Million)
6.3.2. U.S.
6.3.2.1. U.S. estimated disease burden by indication, 2019 -2022
6.3.2.2. Regulatory framework & reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. U.S. home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.3.3. Canada
6.3.3.1. Canada estimated disease burden by indication, 2019 -2022
6.3.3.2. Regulatory framework & reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Canada home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.4. Europe
6.4.1. Europe Home Healthcare Market Estimates and Forecasts, 2021 - 2034 (USD Million)
6.4.2. UK
6.4.2.1. UK estimated disease burden by indication, 2019 -2022
6.4.2.2. Regulatory framework & reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. UK home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.4.3. Germany
6.4.3.1. Germany estimated disease burden by indication, 2019 -2022
6.4.3.2. Regulatory framework & reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. Germany home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.4.4. France
6.4.4.1. France estimated disease burden by indication, 2019 -2022
6.4.4.2. Regulatory framework & reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. France home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.4.5. Italy
6.4.5.1. Italy estimated disease burden by indication, 2019 -2022
6.4.5.2. Regulatory framework & reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Italy Home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.4.6. Spain
6.4.6.1. Spain estimated disease burden by indication, 2019 -2022
6.4.6.2. Regulatory framework & reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Spain home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.4.7. Netherlands
6.4.7.1. Netherlands estimated disease burden by indication, 2019 -2022
6.4.7.2. Regulatory framework & reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Netherlands home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.4.8. Sweden
6.4.8.1. Sweden estimated disease burden by indication, 2019 -2022
6.4.8.2. Regulatory framework & reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Sweden home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.4.9. Ireland
6.4.9.1. Ireland estimated disease burden by indication, 2019 -2022
6.4.9.2. Regulatory framework & reimbursement structure
6.4.9.3. Competitive scenario
6.4.9.4. Ireland home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.4.10. Russia
6.4.10.1. Russia estimated disease burden by indication, 2019 -2022
6.4.10.2. Regulatory framework & reimbursement structure
6.4.10.3. Competitive scenario
6.4.10.4. Russia home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.4.11. Switzerland
6.4.11.1. Switzerland estimated disease burden by indication, 2019 -2022
6.4.11.2. Regulatory framework & reimbursement structure
6.4.11.3. Competitive scenario
6.4.11.4. Switzerland home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.4.12. Denmark
6.4.12.1. Denmark estimated disease burden by indication, 2019 -2022
6.4.12.2. Regulatory framework & reimbursement structure
6.4.12.3. Competitive scenario
6.4.12.4. Denmark home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Home Healthcare Market Estimates and Forecasts, 2021 - 2034 (USD Million)
6.5.2. Japan
6.5.2.1. Japan estimated disease burden by indication, 2019 -2022
6.5.2.2. Regulatory framework & reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Japan home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.5.3. China
6.5.3.1. China estimated disease burden by indication, 2019 -2022
6.5.3.2. Regulatory framework & reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. China home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.5.4. India
6.5.4.1. India estimated disease burden by indication, 2019 -2022
6.5.4.2. Regulatory framework & reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. India home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.5.5. Australia
6.5.5.1. Australia estimated disease burden by indication, 2019 -2022
6.5.5.2. Regulatory framework & reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Australia home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.5.6. South Korea
6.5.6.1. South Korea estimated disease burden by indication, 2019 -2022
6.5.6.2. Regulatory framework & reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. South Korea home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.5.7. Singapore
6.5.7.1. Singapore estimated disease burden by indication, 2019 -2022
6.5.7.2. Regulatory framework & reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Singapore home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.5.8. Thailand
6.5.8.1. Thailand estimated disease burden by indication, 2019 -2022
6.5.8.2. Regulatory framework & reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Thailand home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.5.9. Philippines
6.5.9.1. Philippines estimated disease burden by indication, 2019 -2022
6.5.9.2. Regulatory framework & reimbursement structure
6.5.9.3. Competitive scenario
6.5.9.4. Philippines home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.5.10. Malaysia
6.5.10.1. Malaysia estimated disease burden by indication, 2019 -2022
6.5.10.2. Regulatory framework & reimbursement structure
6.5.10.3. Competitive scenario
6.5.10.4. Malaysia home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.5.11. New Zealand
6.5.11.1. New Zealand estimated disease burden by indication, 2019 -2022
6.5.11.2. Regulatory framework & reimbursement structure
6.5.11.3. Competitive scenario
6.5.11.4. New Zealand home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.6. Latin America
6.6.1. Latin America Home Healthcare Market Estimates and Forecasts, 2021 - 2034 (USD Million)
6.6.2. Brazil
6.6.2.1. Brazil estimated disease burden by indication, 2019 -2022
6.6.2.2. Regulatory framework & reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Brazil home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.6.3. Mexico
6.6.3.1. Mexico estimated disease burden by indication, 2019 -2022
6.6.3.2. Regulatory framework & reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. Mexico home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.6.4. Argentina
6.6.4.1. Argentina estimated disease burden by indication, 2019 -2022
6.6.4.2. Regulatory framework & reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Argentina home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.7. Middle East & Africa
6.7.1. Middle East & Africa SWOT Analysis
6.7.2. Middle East & Africa Home Healthcare Market Estimates and Forecasts, 2021 - 2034 (USD Million)
6.7.3. South Africa
6.7.3.1. South Africa estimated disease burden by indication, 2019 -2022
6.7.3.2. Regulatory framework & reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. South Africa home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.7.4. Saudi Arabia
6.7.4.1. Saudi Arabia estimated disease burden by indication, 2019 -2022
6.7.4.2. Regulatory framework & reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Saudi Arabia home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.7.5. UAE
6.7.5.1. UAE estimated disease burden by indication, 2019 -2022
6.7.5.2. Regulatory framework & reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. UAE home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.7.6. Egypt
6.7.6.1. Egypt estimated disease burden by indication, 2019 -2022
6.7.6.2. Regulatory framework & reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Egypt home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
6.7.7. Oman
6.7.7.1. Oman estimated disease burden by indication, 2019 -2022
6.7.7.2. Regulatory framework & reimbursement structure
6.7.7.3. Competitive scenario
6.7.7.4. Oman home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Company Market Position Analysis: Suppliers
7.3. Company Market Position Analysis: Service Providers
7.4. Strategy Mapping
7.5. Company Profiles: Suppliers
7.5.1. McKesson Medical-Surgical Inc.
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Fresenius Medical Care
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Medline Industries, Inc.
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Medtronic PLC
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. 3M Healthcare
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Baxter International Inc.
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. B. Braun Melsungen AG
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Arkray, Inc.
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. F. Hoffmann-La Roche AG
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. Becton, Dickinson and Company
7.5.10.1. Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives
7.5.11. Acelity L.P.
7.5.11.1. Overview
7.5.11.2. Financial Performance
7.5.11.3. Product Benchmarking
7.5.11.4. Strategic Initiatives
7.5.12. Hollister Inc.
7.5.12.1. Overview
7.5.12.2. Financial Performance
7.5.12.3. Product Benchmarking
7.5.12.4. Strategic Initiatives
7.5.13. ConvaTec Group PLC
7.5.13.1. Overview
7.5.13.2. Financial Performance
7.5.13.3. Product Benchmarking
7.5.13.4. Strategic Initiatives
7.5.14. Molnlycke Health Care
7.5.14.1. Overview
7.5.14.2. Financial Performance
7.5.14.3. Product Benchmarking
7.5.14.4. Strategic Initiatives
7.6. Company Profile: Service Providers
7.6.1. Brookdale Senior Living, Inc.
7.6.1.1. Overview
7.6.1.2. Financial Performance
7.6.1.3. Service Benchmarking
7.6.1.4. Strategic Initiatives
7.6.2. Home Health Services Ltd.
7.6.2.1. Overview
7.6.2.2. Financial Performance
7.6.2.3. Service Benchmarking
7.6.2.4. Strategic Initiatives
7.6.3. Sunrise Carlisle, LP
7.6.3.1. Overview
7.6.3.2. Financial Performance
7.6.3.3. Service Benchmarking
7.6.3.4. Strategic Initiatives
7.6.4. Extendicare, Inc.
7.6.4.1. Overview
7.6.4.2. Financial Performance
7.6.4.3. Service Benchmarking
7.6.4.4. Strategic Initiatives
7.6.5. Care UK Limited
7.6.5.1. Overview
7.6.5.2. Financial Performance
7.6.5.3. Service Benchmarking
7.6.5.4. Strategic Initiatives
7.6.6. Senior Care Centers of America
7.6.6.1. Overview
7.6.6.2. Financial Performance
7.6.6.3. Service Benchmarking
7.6.6.4. Strategic Initiatives
7.6.7. Genesis Healthcare Corp.
7.6.7.1. Overview
7.6.7.2. Financial Performance
7.6.7.3. Service Benchmarking
7.6.7.4. Strategic Initiatives
7.6.8. Sompo Holdings, Inc.
7.6.8.1. Overview
7.6.8.2. Financial Performance
7.6.8.3. Service Benchmarking
7.6.8.4. Strategic Initiatives
7.6.9. Kindred Healthcare, Inc.
7.6.9.1. Overview
7.6.9.2. Financial Performance
7.6.9.3. Service Benchmarking
7.6.9.4. Strategic Initiatives
7.6.10. Home Instead Senior Care, Inc.
7.6.10.1. Overview
7.6.10.2. Financial Performance
7.6.10.3. Service Benchmarking
7.6.10.4. Strategic Initiatives
Chapter 8. Key Recommendations/Key Market Insights
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers